Seeking Alpha

Pfizer (PFE -1.4%) says the European Medicines Agency has issued a positive opinion on the...

Pfizer (PFE -1.4%) says the European Medicines Agency has issued a positive opinion on the conditional marketing authorization of its cancer drug bosutinib in the E.U. for the treatment of certain types of leukemia. Conditional approvals in the E.U. are granted to drugs that address unmet medical needs and whose availability would result in a significant public health benefit.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|